• English
    X

    Google Translate Disclaimer

    The Maryland Department of Information Technology (“DoIT”) offers translations of the content through Google Translate. Because Google Translate is an external website, DoIT does not control the quality or accuracy of translated content. All DoIT content is filtered through Google Translate which may result in unexpected and unpredictable degradation of portions of text, images and the general appearance on translated pages. Google Translate may maintain unique privacy and use policies. These policies are not controlled by DoIT and are not associated with DoIT’s privacy and use policies. After selecting a translation option, users will be notified that they are leaving DoIT’s website. Users should consult the original English content on DoIT’s website if there are any questions about the translated content.

    DoIT uses Google Translate to provide language translations of its content. Google Translate is a free, automated service that relies on data and technology to provide its translations. The Google Translate feature is provided for informational purposes only. Translations cannot be guaranteed as exact or without the inclusion of incorrect or inappropriate language. Google Translate is a third-party service and site users will be leaving DoIT to utilize translated content. As such, DoIT does not guarantee and does not accept responsibility for, the accuracy, reliability, or performance of this service nor the limitations provided by this service, such as the inability to translate specific files like PDFs and graphics (e.g. .jpgs, .gifs, etc.).

    DoIT provides Google Translate as an online tool for its users, but DoIT does not directly endorse the website or imply that it is the only solution available to users. All site visitors may choose to use alternate tools for their translation needs. Any individuals or parties that use DoIT content in translated form, whether by Google Translate or by any other translation services, do so at their own risk. DoIT is not liable for any loss or damages arising out of, or issues related to, the use of or reliance on translated content. DoIT assumes no liability for any site visitor’s activities in connection with use of the Google Translate functionality or content.

    The Google Translate service is a means by which DoIT offers translations of content and is meant solely for the convenience of non-English speaking users of the website. The translated content is provided directly and dynamically by Google; DoIT has no direct control over the translated content as it appears using this tool. Therefore, in all contexts, the English content, as directly provided by DoIT is to be held authoritative.

    Maryland Department of Health
    Cancer

    ​​​​​​​​​​​
    ​

    NAACCR Gold.jpg
    ​ 



    Distinction_Seal_2022_Web_Small.png


    Provided_Data_Seal_2023_Web_Small.png


    ​

    Maryland Cancer Registry Webpage

    MDHLogoJPEG.jpg ​​​

    Mission Statement
    The Maryland Cancer Registry Advisory Committee (CRAC) adopted the following mission statements for MCR:
    • Oversight of activities that implement Health-General Article, §18-203 and §18-204, Annotated Code of Maryland, and COMAR 10.14.01 (cancer reporting statutes and regulations);
    • Timely, cost-effective, complete, and accurate ascertainment of new cases of cancer and benign central nervous system tumors among Maryland residents;
    • Computerization of cancer reports to facilitate ready availability, accessibility, and analysis; and
    • Preparation and dissemination of reports on the incidence and stage of cancer at diagnosis, which provide information on site, county of residence, and date of diagnosis.
    Program History
    • The MCR was initiated in 1982 to collect all incident (new) cancers in the State of Maryland.
    • The Maryland General Assembly enacted Maryland Health-General Articles §§ 18-203 and 18-204, effective July 1, 1991, that mandated reporting of all new cancer cases by hospitals, radiation therapy centers, and freestanding diagnostic laboratories that were licensed in Maryland.  It further mandated the electronic submission of reports to the MCR as of July 1, 1993.

    • ​​The reporting law was amended in 1996 to include reporting of non-hospitalized cancer patients by freestanding ambulatory care facilities, and by physicians whose non-hospitalized cancer patients are not otherwise reported, beginning with cases diagnosed on or after October 1, 1996.

    • In 2001, the Maryland General Assembly passed a law that required the reporting of benign brain and central nervous system tumors to the MCR, effective October 1, 2001.
    Links and Information

    The Maryland Cancer Registry is supported by Maryland General Funds, the Maryland Cigarette Restitution Fund, and by contract number 6NU58DP006333 from the Centers for Disease Control and Prevention, National Program of Central Registries

    ​Staff for the Maryland Cancer Registry: 

    Kimberly S. Stern, Program Manager
    Kimberly.Stern@maryland.gov




    Maryland Cancer Registry
    201 W. Preston Street, Suite 400
    Baltimore, MD  21201
    410-767-4055